Biomea Fusion
Biomea Fusion is a privately held precision medicine company with a mission to revolutionize drug development to create more effective therapies for cancer patients. Biomea Fusion has a development portfolio that targets specific gene alterations which occur in the DNA of patients that translate into key drivers of tumor growth. It is Biomea’s goal to move these potentially breakthrough medicines swiftly through the development process and deliver highly impactful treatments for patients in need. The lead program targets the protein-to-protein interaction between menin and the MLL complex for the treatment of various tumors.
Domain
biomeafusion.com
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$25.0M
Founded
2016
Tech Stack (24 technologies)
Frequently Asked Questions
What technologies does Biomea Fusion use?+
Biomea Fusion uses 24 technologies including Astra, Elementor, Google Analytics.
What industry is Biomea Fusion in?+
Biomea Fusion operates in the Biotechnology industry.
Where is Biomea Fusion based?+
Biomea Fusion is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026